CHONDROITIN OINTMENT

INSTRUCTION for medical use of the medicinal product CHONDROITIN OINTMENT (CHONDROITINIUNGUENTUM)

Composition:

Active ingredient: sodium chondroitin sulfate;

1 g of ointment contains sodium chondroitin sulfate (recalculated to dry substance) 50 mg;

Excipients: dimethyl sulfoxide, lanolin, corn oil, soft white paraffin, purified water.

Pharmaceutical form. Ointment.

Main physicochemical properties: ointment of light yellow color with a characteristic odor.

Pharmacotherapeutic group.

Non-steroidal anti-inflammatory and antirheumatic agents. Chondroitin sulfate. ATC code M01AX25.

Pharmacological properties.

Pharmacodynamics.

The drug exerts chondro-stimulating, regenerative, and anti-inflammatory effects. The active ingredient is sodium chondroitin sulfate, obtained from cartilage tissue of bovine trachea. The drug influences phosphate-calcium metabolism in cartilage tissue, slows down bone tissue resorption, reduces calcium loss, accelerates bone tissue restoration, and inhibits the degeneration process of cartilage tissue. It stimulates the recovery of articular cartilage, reduces joint pain and inflammation, and normalizes the production of synovial fluid.

Pharmacokinetics.

Not determined.

Clinical characteristics.

Indications.

Degenerative-dystrophic joint and spinal disorders (predominantly localized forms): osteoarthritis, osteochondrosis.

Contraindications.

Individual hypersensitivity to the components of the drug. Thrombophlebitis, tendency to bleeding, acute inflammatory processes in the area of application.

Interaction with other medicinal products and other types of interactions.

No interactions with other medicinal products have been established with topical application of the drug.

Special precautions for use

The product should not be applied to affected areas of skin; care should be taken to avoid contact with open wounds, eyes, and mucous membranes.

The product contains dimethyl sulfoxide, which may cause skin irritation.

The product contains lanolin, which may cause local skin reactions (e.g., contact dermatitis).

Use during pregnancy or breastfeeding

Safety and efficacy have not been established; therefore, the product should not be used during pregnancy or breastfeeding.

Ability to affect reaction speed when driving or operating machinery

No effect.

Method of administration and dosage.

The medication is intended for adults. Apply topically.

Apply the ointment 2–3 times daily as a thin layer to the affected skin area, gently rubbing in until completely absorbed.

The duration of treatment is determined individually, depending on the efficacy and tolerability of the therapy. The treatment course usually lasts 2–3 weeks.

Do not exceed the recommended doses or prolong the duration of treatment.

Children.

Not to be used.

Overdose.

Overdose is unlikely. Possible cases of hypersensitivity may occur, requiring discontinuation of the medication and administration of symptomatic therapy.

Side effects.

Allergic reactions are possible, including itching, hyperemia, skin swelling, burning sensation, and rash. If these reactions occur, discontinue use of the product and wash off any residue from the skin.

Shelf life. 3 years.

Do not use the product after the expiry date stated on the packaging.

Storage conditions.

Store in the original packaging at a temperature not exceeding 25 °C, in a place inaccessible to children.

Packaging.

25 g in a tube per carton.

Availability. Over-the-counter (without prescription).

Manufacturer.

LLC "DKP "Pharmaceutical Factory".

Manufacturer's address and location of business activity.

4 Korolyova St., v. Stanishivka, Zhytomyr District, Zhytomyr Oblast, 12430, Ukraine.